Evidence map›Paper›PMID 34211458›Full record

Trial reportFrontiers in immunology2021

High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility.

Kazutoyo Osoegawa, Lisa E Creary, Gonzalo Montero-Martín, Kalyan C Mallempati, Sridevi Gangavarapu, Stacy J Caillier, Adam Santaniello, Noriko Isobe, Jill A Hollenbach, Stephen L Hauser and 2 more

Open access · goldAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Immunogenetics of Multiple Sclerosis in Romanian Patients: Preliminary Data.International journal of molecular sciences · 2025
    Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Kazutoyo OsoegawaHistocompatibility & Immunogenetics Laboratory, Stanford Blood Center, Palo Alto, CA, United States.
Lisa E CrearyHistocompatibility & Immunogenetics Laboratory, Stanford Blood Center, Palo Alto, CA, United States.
Gonzalo Montero-MartínHistocompatibility & Immunogenetics Laboratory, Stanford Blood Center, Palo Alto, CA, United States.
Kalyan C MallempatiHistocompatibility & Immunogenetics Laboratory, Stanford Blood Center, Palo Alto, CA, United States.
Sridevi GangavarapuHistocompatibility & Immunogenetics Laboratory, Stanford Blood Center, Palo Alto, CA, United States.
Stacy J CaillierWeill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, United States.
Adam SantanielloWeill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, United States.
Noriko IsobeDepartment of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Jill A HollenbachWeill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, United States.
Stephen L HauserWeill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, United States.
Jorge R OksenbergWeill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA, United States.
Marcelo A Fernández-ViňaHistocompatibility & Immunogenetics Laboratory, Stanford Blood Center, Palo Alto, CA, United States.
Stanford Blood Center · USUniversity of California, San Francisco · USKyushu University · JPStanford University · US

Funding

The Role of B cells in the Origin and Progression of Multiple SclerosisR35NS111644 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEPHEN L HAUSER · 2019 to 2026
$9.1M
KIR association studies in neurological diseasesU19NS095774 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERNANDEZ-VINA, MARCELO, OKSENBERG, JORGE R. · 2015 to 2019
$7.0M
NINDS NIH HHS R35 NS111644NINDS NIH HHS U19 NS095774
6 · The paper itself

Abstract

Multiple sclerosis (MS) susceptibility shows strong genetic associations with HLA alleles and haplotypes. We genotyped 11 HLA genes in 477 non-Hispanic European MS patients and their 954 unaffected parents using a validated next-generation sequencing (NGS) methodology. HLA haplotypes were assigned unequivocally by tracing HLA allele transmissions. We explored HLA haplotype/allele associations with MS using the genotypic transmission disequilibrium test (gTDT) and multiallelic TDT (mTDT). We also conducted a case-control (CC) study with all patients and 2029 healthy unrelated ethnically matched controls. We performed separate analyses of 54 extended multi-case families by reviewing transmission of haplotype blocks. The haplotype fragment including

Indexed as

AllelesGenetic Predisposition to DiseaseHaplotypesHLA-DP AntigensMultiple SclerosisAdolescentAdultCase-Control StudiesChildFemaleGenotyping TechniquesHumansMaleMiddle AgedHLA-DP Antigenscase-control analysisfamilyhaplotypeHLAmultiple sclerosis (MS)transmission disequilibrium test (TDT)

Identifiers

PMID34211458
PMCPMC8240666
OpenAlexW3165104549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.